跳至主要内容
临床试验/NCT03566225
NCT03566225已完成早期 1 期

Combined Pioglitazone and Clomophene Citrate Versus Combined Metformin and Clomiphene Citrate as First Treatment in Infertile Women With Polycystic Ovary Syndrome

Ain Shams University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2018年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
400
试验地点
1
主要终点
Clinical pregnancy rate

研究概览

简要总结

Participants with PCOS will be divided into two groups then each group will randomly recieve one of the following treatment

  1. metformin will be adminstered in adose of 500 mg 3 times daily for 3 months to group B.
  2. pioglitazone will be administered in adose of 30 mg dialy for 3 months to group A.
  3. Induction of ovulation by clomiphene citate 50 mg tablets to all participants

详细描述

Participants with PCOS will be divided into two groups then each group will randomly recieve one of the following treatment

  1. metformin will be adminstered in adose of 500 mg 3 times daily for 3 months to group B.
  2. pioglitazone will be administered in adose of 30 mg dialy for 3 months to group A.
  3. Induction of ovulation by clomiphene citate 50 mg tablets once or twice dialy 12hours apart starting from the 3rd day of menstrual cycle and continue for five days during treatment with insulin sensitizing agents to group A and B.

Participants with oligomenorrhea will recieve two tablets of noreththisterone 5 mg tab every 12 hours for 5 days to allow for withdrawal bleeding before start ovulation induction

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women age 20_35
  • BMI 18_29.9
  • Women with PCOS(diagnosed by using Rotterdam criteria
  • Infertility is cause for seeking tfeatment

排除标准

  • Causes of infertility other than PCOS.
  • patient refusal.
  • Contraindication of any of the drugs used in the study
  • Cause of oligo/anovulation other than PCOS
  • Current or previous (within the last six month) use of oral contraceptives, glucocorticoids, antiandrogens, antidiabetics, antiobesity drugs or other hormonal drugs.

研究组 & 干预措施

Group A

Active Comparator

Pioglitazone in adose 30 mg tablet will be administered dialy+ clomiphene citrate as ovulation induction

干预措施: Pioglitazone (Drug)

Group A

Active Comparator

Pioglitazone in adose 30 mg tablet will be administered dialy+ clomiphene citrate as ovulation induction

干预措施: Clomiphene Citrate (Drug)

Group B

Placebo Comparator

Metformin in adose 1500 mg dialy will be administered + clomiphene citrate

干预措施: Metformin (Drug)

Group B

Placebo Comparator

Metformin in adose 1500 mg dialy will be administered + clomiphene citrate

干预措施: Clomiphene Citrate (Drug)

结局指标

主要结局

Clinical pregnancy rate

时间窗: 3 months

Pregnancy rate diagnosed by U/S at five weeks after missed menses

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa Abdelbadea Ali Salih

Cairo

Ain Shams University

研究点 (1)

Loading locations...

相似试验